hydroxychloroquine has been researched along with Infarct in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to determine the neuroprotective effects of hydroxychloroquine (HCQ) and the timing of its administration in cerebral ischemia/reperfusion (I/R) in rats." | 8.31 | Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion. ( Babataheri, S; Malekinejad, H; Mosarrezaii, A; Soraya, H, 2023) |
| " The aim of the present study was to determine the neuroprotective effects of hydroxychloroquine (HCQ) and the timing of its administration in cerebral ischemia/reperfusion (I/R) in rats." | 4.31 | Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion. ( Babataheri, S; Malekinejad, H; Mosarrezaii, A; Soraya, H, 2023) |
| "Bone infarcts were also associated with these factors." | 1.36 | A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur. ( Karimifar, M; Karimzadeh, H; Mottaghi, P; Salesi, M; Sayedbonakdar, Z, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babataheri, S | 3 |
| Malekinejad, H | 3 |
| Mosarrezaii, A | 3 |
| Soraya, H | 3 |
| Besutti, G | 1 |
| Bonacini, R | 1 |
| Iotti, V | 1 |
| Marini, G | 1 |
| Riva, N | 1 |
| Dolci, G | 1 |
| Maiorana, M | 1 |
| Spaggiari, L | 1 |
| Monelli, F | 1 |
| Ligabue, G | 1 |
| Guaraldi, G | 1 |
| Rossi, PG | 1 |
| Pattacini, P | 1 |
| Massari, M | 1 |
| Yang, CH | 1 |
| Cheng, CY | 1 |
| Chu, KCW | 1 |
| Hsu, CW | 1 |
| Huang, WC | 1 |
| Salesi, M | 1 |
| Karimifar, M | 1 |
| Mottaghi, P | 1 |
| Sayedbonakdar, Z | 1 |
| Karimzadeh, H | 1 |
| Zenone, T | 1 |
| Knefati, Y | 1 |
| Hong, JY | 1 |
| Lai, CC | 1 |
| Chang, YS | 1 |
| Hsiao, KH | 1 |
| Chou, CT | 1 |
| Chen, WS | 1 |
6 other studies available for hydroxychloroquine and Infarct
| Article | Year |
|---|---|
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Abdominal Visceral Infarction in 3 Patients with COVID-19.
Topics: Abdomen; Aged; Anticoagulants; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; | 2020 |
Man With Right Flank Pain.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Flank Pain; Humans; Hydroxychloroqu | 2020 |
A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur.
Topics: Antirheumatic Agents; Drug Therapy, Combination; Female; Femur; Femur Head Necrosis; Humans; Hydroxy | 2010 |
[Renal infarction in systemic lupus with antiphospholipid syndrome: role of hydroxychloroquine withdrawal? Comment on the article by Szymezak et al].
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Anticoagulants; Antiphospholipid Syndro | 2011 |
Intestinal vasculitis and renal infarction in a lupus patient with antiphospholipid syndrome.
Topics: Adolescent; Antiphospholipid Syndrome; Comorbidity; Drug Therapy, Combination; Female; Humans; Hydro | 2012 |